Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05163392 · ClinicalTrials.gov registry record · NA
A Silver Lining in the VAD Sky
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT05163392 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 25 participants.
The verdict
NCT05163392, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The investigators propose to conduct a prospective randomized trail (RCT) of a driveline management protocol. The study will be initiated at UCSF from January 1st 2022 to December 31st 2022 as a pilot to be extended to other sites with the ultimate goal to develop a multi-center RCT. The driveline dressing protocol studied will include a silver-based dressing barrier as well as a dressing change protocol and material designed to reduce the risk of driveline dressing induced dermatitis and allergies. Assessment will include DLI rates, DLI speciation, dermatitis rate, comfort, ease of use, compliance and cost
Interventions
- DEVICE Control
- DEVICE Silverlon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2026-01-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05163392
The ClinicalTrials.gov registry entry for NCT05163392 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT05163392 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05163392 about?
NCT05163392 is a clinical study titled "A Silver Lining in the VAD Sky". The investigators propose to conduct a prospective randomized trail (RCT) of a driveline management protocol. The study will be initiated at UCSF from January 1st 2022 to December 31st 2022 as a pilot to be extended to other sites with the ultimate goal to develop a multi-center RCT. The driveline d...
What is the current status of trial NCT05163392?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2022-02-01. Estimated completion is 2026-01-26.
What interventions are being tested in trial NCT05163392?
The interventions under investigation include: Control (DEVICE), Silverlon (DEVICE).
Who is sponsoring clinical trial NCT05163392?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.